Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Company

Reviva Pharmaceuticals Holdings

Tracked across 3 events · 99 articles · First seen May 13, 2026 · Last active Jul 01, 2026

Sentiment
25
Attention
7
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 20
Business
Impact: Reviva Pharmaceuticals Holdings reported its Q1 2026 financial results, including a reduced net loss and increased cash, and provided updates on its brilaroxazine development program, including a new patent application and upcoming Phase 3 trial. Its stock will transition from Nasdaq-100 to OTCQB Venture Market.
May 13, 2026 · 6 articles
7 55
International
Impact: Reviva Pharmaceuticals Holdings is building overseas industrial ecosystems, accelerating the global expansion of Chinese TCM and heritage wellness brands.
Jun 15, 2026 · 87 articles
2 0
Business
Impact: Reviva Pharmaceuticals Holdings was one of the presenting companies at the Life Sciences Virtual Investor Forum.
Jun 26, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Reviva Pharmaceuticals Holdings live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.